U.S. and British researchers have identified two separate genetic signatures, namely two distinctive patterns of RNA that seem to predict whether patients are afflicted with a mild or aggressive form of prostate cancer. These findings are significant, particularly as castration-resistant prostate cancer does not respond to standard androgen-deprivation therapy. According to the researchers, "patients with a distinctive nine-gene pattern characteristic of aggressive prostate cancer survivied an average of 9.2 months, compared with 21.6 months for those without the gene pattern."
To read more about this study, click here.
No comments:
Post a Comment